药品名称 | GLUCOTROL XL | 申请号 | 020329 | 产品号 | 001 | 活性成分 | GLIPIZIDE | 市场状态 | 处方药 | 剂型或给药途径 | TABLET, EXTENDED RELEASE;ORAL | 规格 | 5MG | 治疗等效代码 | AB | 参比药物 | 否 | 批准日期 | 1994/04/26 | 申请机构 | PFIZER INC
| 化学类型 | New dosage form | 审评分类 | Standard review drug |
|
|
|
与本品相关的市场独占权保护信息 | 独占权代码 | 失效日期 | 无 | 历史市场独占权保护信息 | 无 |
|
与药品注册相关的信息 | 申请号 | 修订号 | 审批结论 | 公开文档类型 | 文档创建时间 | 获取文档 | 020329 | 029 | AP | Letter | 2015/10/06 | 下载 | 020329 | 029 | AP | Label | 2015/10/08 | 下载 | 020329 | 028 | AP | Letter | 2013/10/16 | 下载 | 020329 | 028 | AP | Label | 2013/10/22 | 下载 | 020329 | 025 | AP | Label | 2011/02/07 | 下载 | 020329 | 025 | AP | Letter | 2011/02/09 | 下载 | 020329 | 024 | AP | Label | 2009/09/17 | 下载 | 020329 | 022 | AP | Letter | 2008/10/29 | 下载 | 020329 | 022 | AP | Label | 2008/11/07 | 下载 | 020329 | 015 | AP | Review | 2007/07/09 | 下载 | 020329 | 015 | AP | Letter | 2003/09/29 | 下载 | 020329 | 003 | AP | Review | 2006/10/25 | 下载 | 020329 | 002 | AP | Letter | 2002/04/01 | 下载 | 020329 | 002 | AP | Label | 2002/04/01 | 下载 |
|
药品注册审批历史信息 | 申请号 | 修订号 | 审批结论 | 审批日期 | 审批内容 | 020329 | 029 | AP | 2015/10/05 | Labeling Revision | 020329 | 028 | AP | 2013/10/15 | Labeling Revision | 020329 | 025 | AP | 2011/02/07 | Labeling Revision | 020329 | 024 | AP | 2009/08/31 | Labeling Revision | 020329 | 022 | AP | 2008/10/27 | Packaging Addition | 020329 | 015 | AP | 2003/09/17 | Labeling Revision | 020329 | 013 | AP | 2001/10/26 | Labeling Revision | 020329 | 012 | AP | 2001/06/25 | Manufacturing Change or Addition | 020329 | 011 | AP | 2000/10/31 | Control Supplement | 020329 | 010 | AP | 2001/01/16 | Manufacturing Change or Addition | 020329 | 009 | AP | 2000/07/26 | Manufacturing Change or Addition | 020329 | 008 | AP | 2000/10/26 | Manufacturing Change or Addition | 020329 | 007 | AP | 2000/04/17 | Control Supplement | 020329 | 006 | AP | 2001/09/05 | Labeling Revision | 020329 | 005 | AP | 1999/12/15 | Package Change | 020329 | 004 | AP | 1999/11/18 | Manufacturing Change or Addition | 020329 | 003 | AP | 1999/08/10 | Control Supplement | 020329 | 002 | AP | 2002/04/01 | Efficacy Supplement with Clinical Data to Support | 020329 | 001 | AP | 1998/02/04 | New or Modified Indication | 020329 | 000 | AP | 1994/04/26 | Approval |
|